All In MedTech

Device Trial Radar · NCT07178314

At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women

Evaluating the Feasibility and Efficacy of At-Home Transcutaneous Tibial Nerve Stimulation (TTNS) for Overactive Bladder in Rural Women

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

38

Planned (sponsor's estimate)

Start

Oct 6, 2025

Primary completion

Mar 2027

Study completion Mar 2027

Sponsor

Lead sponsor
Oregon Health and Science UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
American Urogynecologic Society
First posted
Sep 17, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study contains a mixed-methods design consisting of a single-arm, interventional study and prospective patient interviews evaluating a novel self-implemented at-home Transcutaneous Tibial Nerve Stimulation (TTNS) treatment protocol for management of treatment naïve overactive bladder (OAB) among rural-dwelling women. This study will be conducted in 3 rural Oregon communities where Oregon Health \& Science University satellite campuses are located.

Conditions

  • Overactive Bladder

Interventions

  • Transcutaneous Tibial Nerve Stimulation (TTNS)Device

    Participants will perform self-implemented at-home transcutaneous tibial nerve stimulation using a transcutaneous electrical nerve stimulation (TENS) unit. Participants will be instructed to use the TENS unit to deliver stimulation to the tibial nerve on one ankle for a 30-minute session, three times per week for 12 weeks upon receipt of the device. Intensity will be based on the participant's tolerance, just above the perception threshold but not painful.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overactive Bladder questionnaire short form (OAB-q SF) Health-related Quality of lifeTime frame: Evaluated upon enrollment and following 12 weeks of intervention
  2. Overactive Bladder questionnaire short form (OAB-q SF) symptom botherTime frame: Evaluated upon enrollment and following 12 weeks of intervention
  3. 24-hour voiding frequencyTime frame: 3-day voiding diary completed upon enrollment and following 12 weeks of intervention

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Oregon Health & Science University

    Portland, Oregon · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.